The present study was conducted to investigate growth performance, carcass characteristics, short-chain fatty acids, fatty acid composition in abdominal fat, and serum parameters in broiler chickens fed diets containing corn oil, coconut oil, or black soldier fly larvae ( BSFL ) oil at the level of 50 g per kg of diet during the 30-day-feeding period. A total 450 one-day-old male broiler chicks (Ross 308) were randomly allocated to one of 3 dietary groups. Each treatment had 10 replicates with 15 chicks per replicate. Feed conversion ratio was decreased in the coconut and BSFL oil group compared with the corn oil group. Dietary BSFL oil increased ileal weight-to-length ratio at day 30 after hatch. Dietary BSFL oil increased significantly ileal branched-chain fatty acid ( P < 0.05) and moderately total short-chain fatty acid in 15-day-old broilers ( P = 0.074). At day 30, ileal propionate was highest in the coconut oil group but cecal propionate was highest ( P < 0.05) in the BSFL oil group. Fatty acid composition of abdominal fat was affected by dietary fat sources. Especially, chickens fed diets containing coconut oil or BSFL oil had higher contents ( P < 0.05) of saturated fatty acid being dominant in lauric and myristic acids compared with those fed on corn oil. On the other hand, the reverse trend was noted ( P < 0.05) as to polyunsaturated fatty acids being dominant in corn oil compared with coconut oil and BSFL oil. Coconut oil vs. corn oil significantly increased total and high-density lipoprotein cholesterol. Finally, BSFL oil vs. corn oil significantly increased total antioxidant capacity in chickens. It is concluded that dietary BSFL oil improves feed conversion ratio and increases the incorporation of medium-chain fatty acids into abdominal fat pad and serum antioxidant capacity in broiler chickens.
The present study was conducted to evaluate the effects of dietary gamma-aminobutyric acid (GABA) in broiler chickens raised in high stocking density (HSD) on performance and physiological responses. A total of 900 male broiler chicks (Ross 308) at 1 d old were assigned in a 2 × 2 factorial arrangement to 4 treatments (10 replicates per treatment) with stocking density, 7.5 birds/m 2 (low stocking density; LSD) or 15 birds/m 2 (HSD), and dietary GABA, 0 or 100 mg/kg. Chickens raised in HSD exhibited a decrease in body weight gain in all phases ( P < 0.05) and feed intake in starter and whole phases ( P < 0.01), and an increase in feed conversion ratio in the finisher phase ( P < 0.01) compared with LSD-raised chickens. However, dietary GABA did not affect growth performance nor interacted with stocking density on production variables. The HSD vs. LSD increased relative liver weight on d 35 whereas dietary GABA increased relative liver weight and decreased relative bursa weight on d 21. Both stocking density and dietary GABA affected yield and quality of breast and leg muscles. Dietary GABA increased ( P < 0.05) width of tibia on d 35 and interacted ( P = 0.054) with stocking density on breaking stocking density on d 35. The HSD vs. LSD group lowered ( P < 0.05) feather coverage scores. Significant interaction between stocking density and GABA on surface temperature of shank on d 21 was noted ( P = 0.024). Dietary GABA exhibited an opposite effect on the concentrations of cecal short-chain fatty acids depending on stocking density leading to a moderate to significant interaction. Stocking density decreased alpha-1-acid glycoprotein whereas dietary GABA decreased heterophil-to-lymphocyte ratio and corticosterone in blood or serum samples. Serum biochemical parameters were altered by stocking density or dietary GABA. It is concluded that dietary GABA alleviated stress indices including corticosterone and heterophil-to-lymphocyte ratio, but failed to reverse stocking density-induced growth depression.
The present study was conducted to evaluate the encapsulated essential oils (EEO) as an alternative to anticoccidials using a coccidiosis vaccine challenged model in broiler chickens. A total of 600 one-day-old male broiler chicks were provided with no added corn/soybean-meal-based control diet or diets that contained either salinomycin (SAL) or thymol- and carvacrol-based EEO at 60 and 120 mg per kg of diet. Before challenge at 21 days, each treatment had 10 replicates except for the no-added control group, which had 20 replicates. On day 21, half of the control groups were orally challenged with a coccidiosis vaccine at 25 times higher than the recommended vaccine dose. During 22 to 28 days (i.e., one-week post coccidiosis vaccine challenge), the challenged chickens had a decrease (P < 0.05) in body weight gain and feed intake but an increase in feed conversion ratio compared with the non-challenged, naïve control chickens. However, dietary EEO significantly counteracted (P < 0.05) coccidiosis-vaccine-induced depression in body weight gain and feed intake. Inclusion of dietary EEO linearly decreased (P < 0.05) the concentrations of the volatile fatty acids. Dietary SAL and EEO affected gut morphology in chickens at 20 days post-hatch. Dietary EEO linearly (P = 0.073) increased serum catalase activity as the inclusion level increased. Collectively, our study shows that dietary EEO increased coccidiosis-vaccine-induced growth depression and altered gut physiology in broiler chickens. Our study adds to the accumulating evidence that dietary EEO is proven to be an effective alternative to anticoccidials for broiler chickens.
The present study was conducted to evaluate encapsulated essential oils as an alternative anticoccidial in coccidiosis vaccine challenged broiler chickens. A total of 600 day-old male broiler chicks were provided with no-added corn-soybean meal-based control diet or diets that contained either salinomycin or EO at 60 and 120 mg per kg of diet. On day 21, half of the control groups were orally challenged with a coccidiosis vaccine at 25 times higher than the recommended vaccine dose. During 22 to 28 days (i.e., one-week post coccidiosis vaccine challenge), the challenged chickens had decrease (P < 0.05) in body weight gain and feed intake but increase in feed conversion ratio compared with the non-challenged, naïve control chickens. However, dietary EO significantly counteracted (P < 0.05) coccidiosis vaccine-induced depression in body weight gain and feed intake. Increasing dietary EO linearly decreased (P < 0.05) the concentrations of the volatile fatty acids. Dietary SAL and EO affected gut morphology in chickens at 20 days posthatch. Increasing dietary EO linearly (P = 0.073) increased serum catalase activity. Collectively, our study shows that dietary EO increased coccidiosis vaccine-induced growth depression and altered gut physiology in broiler chickens.
This study was performed to evaluate the effect of the level of stocking density of housing with or without window on chicken meat quality. The incidence of 1 + grade of whole chicken housed with window significantly influenced by stocking density. /head) was 26, 52, and 66%, respectively. Breast muscle of chicken housed with window and with low stocking density showed higher incidence of 1 + grade than high stocking density. Also minor and severe PSE (pale, soft, extractive) incidence of chicken meat were showed 4% each, while the 1 + grade chicken was not appeared at low density. In chicken thigh, the incidence rate was not affected by stocking density. In chicken housed without window, the incidence of 1 + grade chicken in high, standard, and low stocking density was 18, 8, and 46%, respectively. Also, the incidence of 1 + grade chicken breast was 2.6 times higher than the chicken in low stocking density. However, incidence of 1 + grade thigh was not affected by the stocking density. These results suggest that high stocking density significantly reduced the incidence of 1 + grade chicken meat regardless of housing with or without window.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.